September 02, 2025

New Bruton’s Tyrosine Kinase Inhibitor Improves Platelet Response

The FDA has approved rilzabrutinib (Wayrilz) as the first Bruton’s tyrosine kinase inhibitor for adults with chronic or persistent immune thrombocytopenia who have had an insufficient response to prior therapy.

Conexiant

September 02, 2025

Robotic Surgery May Improve Emergency Colectomy Outcomes

Expanding robotic surgery in urgent settings.

Conexiant

September 02, 2025

Survey Identifies Risk Factors for Adolescent Voice Disorders

Family history and interconnected systems may shape chronic vocal problems in adolescents.

Conexiant

August 29, 2025

Gastrointestinal Foreign Bodies: When to Use Computed Tomography Versus Radiograph

A physician-focused review of gastrointestinal foreign body ingestion is looking to guide triage and intervention.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

Polymerase Mutations Shape Distinct Cancer Risks

Germline mutations in POLE and POLD1 are linked to variable cancer risks, with findings highlighting mutation-specific differences that refine tumor predisposition assessment.

Conexiant

August 28, 2025

Study Identifies Age-Specific Prediabetes Mortality Risk

Researchers found in over 38,000 US adults that prediabetes was linked to higher mortality risk only in those aged 20 to 54 years.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 27, 2025

Fast Walking Tied to Longer Life

As little as 15 minutes per day of fast walking was linked to 19% lower all-cause mortality.

Conexiant